Author(s):
Prachi Rajesh Patil, Javesh K. Patil
Email(s):
prachirpati12323@gmail.com
DOI:
10.52711/2231-5675.2026.00004 
Address:
Prachi Rajesh Patil1*, Javesh K. Patil2
1Students, P.S.G.V.P.M’s College of Pharmacy, Shahada, Dist- Nandurbar, 425409, Maharashtra, India.
2Assistant Professor, Department of Pharmaceutical Quality Assurance, P.S.G.V.P.M’s College of Pharmacy, Shahada, Dist- Nandurbar, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2026
ABSTRACT:
Due in large part to the rise of Mycobacterium tuberculosis strains that are extensively drug-resistant (XDR) and multidrug-resistant (MDR), tuberculosis (TB) continues to be a significant worldwide health concern. Combination therapy is crucial for reducing treatment time, increasing effectiveness, and preventing the emergence of resistance. A validated reverse-phase high-performance liquid chromatography (RP-HPLC) approach was utilized to concurrently estimate levofloxacin (LEV), a fluoroquinolone used in cases of resistant tuberculosis, and rifampicin (RIF), a first-line antitubercular drug. Using a mobile phase of 0.03 M potassium dihydrogen phosphate buffer (pH 3.0): acetonitrile (55:45 v/v) at a flow rate of 0.8mL/min and a detection wavelength of 230nm, the chromatographic separation was accomplished on a Kinetics C18 column (250mm × 4.6mm, 5µm). With correlation values (r²) of 0.9985 and 0.9994, respectively, the technique demonstrated linearity over 1–5µg/mL for RIF and 2–10µg/mL for LEV. RIF and LEV had limits of detection (LOD) of 0.0921µg/mL and 0.0914µg/mL, respectively, and limits of quantitation (LOQ) of 0.2790µg/mL and 0.2771 µg/mL. Method reliability was confirmed by accuracy ranging from 98.14 to 101.32% and precision (%RSD) being less than 2%. A 2–¹ fractional factorial design was used to assess robustness, and the results showed that flow rate and acetonitrile concentration had a substantial impact on chromatographic parameters. A synthetic mixture including RIF and LEV with PLGA polymer was successfully analyzed using the described approach. All things considered, this validated RP-HPLC approach is straightforward, quick, precise, and appropriate for routine quality control applications as well as simultaneous estimation of levofloxacin and rifampicin in mixed dose forms.
Cite this article:
Prachi Rajesh Patil, Javesh K. Patil. Analytical method development and validation for Simultaneous Estimation of Rifampicin and Levofloxacin in Bulk and Synthetic Mixtures Using Validated RP- HPLC Technique. Asian Journal of Pharmaceutical Analysis. 2026; 16(1):21-8. doi: 10.52711/2231-5675.2026.00004
Cite(Electronic):
Prachi Rajesh Patil, Javesh K. Patil. Analytical method development and validation for Simultaneous Estimation of Rifampicin and Levofloxacin in Bulk and Synthetic Mixtures Using Validated RP- HPLC Technique. Asian Journal of Pharmaceutical Analysis. 2026; 16(1):21-8. doi: 10.52711/2231-5675.2026.00004 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2026-16-1-4
5. REFERENCES:
1. World Health Organization. WHO global tuberculosis Report. Geneva: WHO; 2016.
2. Hall RG, Leff RD, Gumbo T. Treatment of active pulMonary tuberculosis in adults: current standards and Recent advances. Pharmacother. 2009; 29: 1468–1481.
3. O’Neil MJ, editor. The merck index an encyclopedia of chemicals, drugs, and biologicals. 13th ed. Whitehouse Station (NJ): Merck and Co., Inc.; 2001. p. 1474.
4. Maggi N, Pasqualucci CR, Ballota R, et al. Rifampicin: A new orally active rifamycin. Chemother. 1966; 11: 285–292.
5. Rees RJW, Pearson JMH, Waters MFR. Experimental and Clinical studies on rifampicin in treatment of leprosy. Br Med J. 1970; 1: 89–92.
6. Binda G, Domenichini E, Gottardi A. Rifampicin, a general Review. Arzneim Forsch. 1971; 21: 1907–1977.
7. Pähkla R, Lambert J, Ansko P, et al. Comparative bioavail-Ability of three different preparations of rifampicin. J Clin Pharm Ther. 1999; 24: 219–225.
8. Tsankov N, Angelova I. Rifampin in dermatology. Clin Dermatol. 2003; 21: 50–55.
9. Berning, S.E. The role of fluoroquinolones in tuberculosis today. Drugs 2001; 61: 9–18.
10. Jacobs, M.R. Activity of quinolones against mycobacteria. Drugs 1999; 58: 19– 22. [CrossRef]
11. Pham, D.D.; Fattal, E.; Tsapis, N. Pulmonary drug delivery systems for tuberculosis treatment. Int. J. Pharm. 2015; 478: 517–529.[CrossRef]
12. Chopra, H.; Mohanta, Y.K.; Rauta, P.R.; Ahmed, R.; Mahanta, S.; Mishra, P.K.; Panda, P.; Rabaan, A.A.; Alshehri, A.A.; Othman, B.; et al. An insight into advances in developing nanotechnology based therapeutics, drug delivery, diagnostics and vaccines: Multidimensional applications in tuberculosis disease management. Pharmaceuticals 2023; 16: 581. [CrossRef]
13. Razzaq, S.N.; Khan, I.U.; Mariam, I.; Razzaq, S.S. Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations. Chem. Cent. J. 2012; 6: 94. [CrossRef]
14. http://dx.doi.org/10.13005/msri/110109(Received: August 15, 2014; Accepted: August 29, 2014)
15. Le-Deygen, I.M.; Skuredina, A.A.; Mamaeva, P.V.; Kolmogorov, I.M.; Kudryashova, E.V. Conjugates of chitosan with β-Cyclodextrins as promising carriers for the delivery of levofloxacin: Spectral and microbiological studies. Life 2023; 13: 272.[CrossRef]
16. Vishwanathan K, Bartlett MG, Stewart JT. Determination of Gatifloxacin in human plasma by liquid Chromatography/ electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 2001; 15(12): 915-9.
17. Singh RK, Rathnam MV, Singh SJ, Vegesna RV. Determination of Camylofin dihydrochloride and Nimesulide in Pharmaceutical Preparation by Gas chromatography. American Journal of Analytical Chemistry. 2011; 2(8): 944.
18. Natesan S, Thanasekaran D, Krishnaswami V, Ponnusamy C. Improved RP-HPLC method for the simultaneous estimation of Tranexamic acid and mefenamic acid in tablet dosage form. Pharm. Anal. Acta. 2011; 2(1): 115.
19. Puozzo C, Filaquier C, Zorza G. Determination of milnacipran, a Serotonin and noradrenaline reuptake inhibitor, in human Plasma using liquid chromatography with spectrofluorimetric Detection. Journal of Chromatography B. 2004; 806(2): 221-8.
20. Shinozuka T, Terada M, Tanaka E. Solid-phase extraction and Analysis of 20 antidepressant drugs in human plasma by LC/MS With SSI method. Forensic Science International. 2006; 162(1-3): 108-12.
21. Zhang LJ, Yao YM, Sun JJ, Chen J, Jia XF. An LC–MS/MS Method for Simultaneous Quantification of Seven Anti-HIV Medicines in Plasma of HIV-infected Patients. Pharm Anal Acta. 2010; 1(1): 1.
22. Rajender G, Narayana NG. Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Paclitaxel in Human Plasma. Pharm Anal Acta. 2010; 1: 101.
23. Sharma HK, Jain N, Jain SK. Development of spectrophotometric Method for quantitative estimation of Amlodipine besylate, Olmesartan medoxomil and hydrochlorthiazide in tablet dosage Form. Pharm Anal Acta. 2011; 2(126): 2.
24. International Conference on Harmonization. ICH Q2 (R1): validation of analytical procedures: text and methodology, ICH Secretariat, Geneva, 2005.
25. United States Pharmacopeia 27, national formulary 22,vol.2, The United States Pharmacopoeial Convention, Rockville, 2003. p. 2281.
26. Zar JH. Biostatistical analysis. 5th ed Upper saddle River(NJ): Pearson Educational Publications; 2010.
27. Kleinschmidt G. Method validation in pharmaceutical analysis. In: Ermer J, Miller JHM, editor. A guide to best practice. Weinheim: Wiley-VCH Verlag GmbH and Co. KGaA; 2005. p.70
28. Annapurna MM, Mohapatra C, Narendra A. Stability-indicating liquid chromatographic method for the deter-mination of Letrozole in pharmaceutical formulations. J Pharm Anal. 2012; 2: 298–305.